MedPath

Effect of peer-group therapy on medication adherence among patients of diabetes and/or hypertension in rural settings across India

Phase 3
Conditions
Health Condition 1: I10- Essential (primary) hypertensionHealth Condition 2: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2024/01/061939
Lead Sponsor
Indian Council of Medical Research (ICMR)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Diagnosed case of diabetes and/or hypertension and are on medication(s).

2 Male or female aged 18 years or more.

3 Resident of village during the baseline survey.

4 Has no plans to migrate in next 12 months from the date of initiation of intervention.

Exclusion Criteria

1 Persons who cannot provide informed consent or decline participation in the study

2 Persons with a terminal medical condition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is the improvement in medication adherence in diabetes and/or hypertension as measured using Morisky Medication Adherence Scale (MMAS 8).Timepoint: The outcome will be measured at 4th, 7th & 12th month and will be compared with the baseline
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes include improvement in health literacy measured using AAHLS (All Aspects of Health Literacy Scale), clinical outcomes related to diabetes & hypertension measured using Hb1AC & blood pressure measurement, quality of life measured using EURO-QoL (EQ-5D) & service user satisfaction measured using PSQ-18 (Patient Satisfaction Questionnaire Short Form). <br/ ><br>Along with this, process evaluation & return on investment (ROI) will be done. <br/ ><br>Timepoint: The outcomes of Health literacy, Clinical outcomes, <br/ ><br>Quality of life, <br/ ><br>Service User Satisfaction <br/ ><br>will be measured at 4th, 7th & 12th month & will be compared with the baseline. Process evaluation & return on investment (ROI) will be measured throughout the study.
© Copyright 2025. All Rights Reserved by MedPath